Sangamo Therapeutics: Q4 Earnings Insights

Sangamo Therapeutics SGMO reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Sangamo Therapeutics beat estimated earnings by 23.53%, reporting an EPS of $-0.26 versus an estimate of $-0.34.

Revenue was up $2.19 million from the same period last year.

Last quarter the company beat on EPS by $0.01 which was followed by a 0.73% increase in the share price the next day.

Here's a look at Sangamo Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.34	-0.31	-0.30	-0.21
EPS Actual	-0.33	-0.33	-0.32	-0.29
Revenue Estimate	25.19M	26.48M	23.98M	32.15M
Revenue Actual	28.56M	27.87M	26.28M	25.80M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar